Backing biosimilars

The Pharmacy Guild of Australia has backed the TGA’s policy of biosimilar substitution by pharmacists in a new position statement released this week.

The new policy acknowledges the use of biosimilars is a safe and effective cost saving measure for government and patients, the Guild says.

The policy has attracted criticism, both in Australia and internationally

“The TGA follows a rigorous and detailed assessment for registered medicines, with sponsors required to provide comprehensive data which is evaluated by the TGA, as well as